Survey: Despite AI’s Growing Impact on the Workplace, Most HR Leaders Are Not Focused on Reskilling Workers
NEW YORK, Jan. 7, 2025 /PRNewswire/ — As businesses discover new ways to capitalize on the benefits of AI, a new survey from The Conference Board reveals that HR leaders are not prioritizing the reskilling of workers that will be the most impacted by AI’s use. Only 7% of CHROs say they a
SAFCO Closes $100 Million Warehouse Facility with Deutsche Bank, Renews Existing Capital One Facility Through 2028
POMPANO BEACH, Fla., Jan. 7, 2025 /PRNewswire/ — Southern Auto Finance Company, LLC (“SAFCO”), a financial services industry leader, is pleased to announce the successful closing of a $100 million warehouse facility with Deutsche Bank, marking a significant milestone in the company
Cellulase Market Analysis 2024-2030: Insights into Biofuels, Animal Feed, and Textile Applications | Valuates Reports
BANGALORE, India, Jan. 7, 2025 /PRNewswire/ — Cellulase Market is Segmented by Type (EG, CBH, BG), by Application (Animal Feed, Textile, Food & Beverage, Biofuels). The Global Cellulase market was valued at USD 1317 Million in 2023 and is anticipated to reach USD 2009 Million by 2030, witn
PATTEN PROPERTIES: WHY BUYING LAND IS A SMART CHOICE IN 2025’S CHANGING MARKET
DALLAS, Jan. 7, 2025 /PRNewswire/ — As the U.S. real estate market approaches 2025, significant challenges such as a housing shortage, rising material costs, and labor shortages are reshaping the landscape. However, these conditions also present unique opportunities for land buyers. With over
Zydus announces agreement with CVS Caremark to add Zituvio™, Zituvimet™ and Zituvimet™ XR (Sitagliptin | Sitagliptin and Metformin Hydrochloride) to its template formulary
AHMEDABAD, India, Jan. 7, 2025 /PRNewswire/ — Zydus Lifesciences Ltd. (including its subsidiaries/affiliates, hereafter referred to as ‘Zydus’), a global innovation driven healthcare company announced that it has entered into an agreement with CVS Caremark®, a CVS Health® (NYS
MUELLER SPORTS MEDICINE ACQUIRES THE PRO ORTHOPEDIC BRAND
PRAIRIE DU SAC, Wis., Jan. 7, 2025 /PRNewswire/ — Mueller Sports Medicine, a global leader in the design, manufacture and distribution of high-quality sports medicine products, proudly announces the acquisition of the iconic Pro Orthopedic brand, a renowned provider of Neoprene products for bo
BionicM Announces Launch of U.S. Headquarters and Unveils Bio Leg®, Awarded CES 2025 Best of Innovation
TOKYO, Jan. 7, 2025 /PRNewswire/ — BionicM (CEO: Sunny Xiaojun Sun, Ph.D) is thrilled to announce the launch of its U.S. subsidiary, BionicM USA, located in the Virginia area near Washington, D.C. This strategic move reinforces the company’s commitment to delivering advanced powered micr
Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025
CRANFORD, N.J., Jan. 7, 2025 /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius Pharma” or the “Company”) (Nasdaq: CTXR) and its oncology-focused subsidiary, Citius Oncology (Nasdaq: CTOR), today announced significant progress in preparations for the commercial launch
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Dr. Jonathan Javitt and Dr. David Feifel to Present Keynote Address, Beyond Ketamine Monotherapy: Combined Interventional Treatment of Suicidal Depression and PTSD, at the 8th Annual Neuroscience Innovation Forum in San Francisco
The Keynote Address, entitled “Beyond Ketamine: Combined Interventional Treatment of Suicidal Depression and PTSD,” will be presented at 10:30AM PT on Sunday January 12th, 2025 Prof. David Feifel MD PHD, designated Chief Medical Innovation Officer of HOPE and Founder of the Kadima Neuro
Mediplex Property Group Marks a Year of Significant Milestones in 2024
FORT WASHINGTON, Pa., Jan. 7, 2025 /PRNewswire/ — Mediplex Property Group is pleased to announce key accomplishments in 2024, underscoring its continued success as a premier assignment-driven real estate developer and investor. In the first quarter of 2024, the firm successfully completed the
